Tune Therapeutics (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- May 19, 2025
- Vertical
- Epigenome Editing
- Funding URL
- View Funding Page
- Funding Amount:
- $175,000,000
Company Info
- Company Description
- Tune Therapeutics is a leading epigenome editing company focused on developing innovative therapies through precise epigenetic modifications.
- Market
- Biotechnology
- Location
- Durham, North Carolina, USA
- Coinvestors
- New Enterprise Associates, Yosemite, Regeneron Ventures, Hevolution Foundation